Brown & Brown CEO Rules Out A 'Multi-Hundred-Million-Dollar Program' For AI, Will Budget One Year At A Time
Powell Brown says the insurance broker will fund AI in one-year tranches tied to expected returns, with the 2027 plan due in January.
Brown & Brown, the insurance agency and wholesale broker, will not announce a large multi-year AI spending program, CEO Powell Brown told analysts on the company's third-quarter earnings call. It will instead fund AI in one-year tranches that tie dollars to the returns it expects.
One-year tranches, not a mega-program
"To give a preview, we will not announce a multi-year, multi-hundred-million-dollar program," Brown said. The landscape is evolving quickly, he said, and the prudent approach is measurable one-year tranches that tie the dollars invested more closely to expected returns.
The 2027 plan, including investments and related benefits, will be laid out with year-end earnings. Pressed by a Jefferies analyst on whether technology spending will rise further, Brown said the company is finalizing the numbers and will lay out a one-year 2027 spend and projected benefits in January.
He said the company deployed Claw, an AI platform, to over 6,000 teammates in 45 days, with more than 90% actively using it, and is rolling it out to the next group. Brown called AI "an accelerator" rather than a disruptor to the company's model. A value management office now measures investments and returns by initiative.
Producer-loss talk and a weak specialty arm
Executive Vice President and Chief Financial Officer R. Andrew Watts answered a Goldman Sachs analyst's question about talk that the company has lost "all kinds of producers" since buying Accession. He called that "absolutely factually incorrect" and said retention of legacy Accession producers is in line with Brown & Brown's. Brown separately said retention at the acquired business was very similar before the one-year mark.
Third-quarter revenue was $1.7 billion, up 7.4%, with organic growth of 1.2%. Adjusted earnings per share rose nearly 2% to $1.07, and the adjusted EBITDA margin fell 200 basis points to 34.6%. Retail's organic growth was 2.6%, while Specialty Distribution's fell 80 basis points, below the company's expectations. Brown & Brown repurchased $750 million of shares in the first nine months, including $250 million in the third quarter.
Shares were down about 5% to $67.58 in trading after the call, against a previous close of $71.08, giving the company a market value of about $23.8 billion.
Outlook and the January budget
Brown & Brown sells property, casualty and employee benefits coverage, mostly as an agent or broker. It guided to fourth-quarter organic growth of 2% to 3% in Retail and a decline of 2% to 4% in Specialty Distribution. For 2027 it expects organic growth of 2% to 4% in Retail and 1% to 3% in Specialty Distribution, ranges Watts said may be adjusted once year-end results are final.
Watts also raised the Accession synergy targets, to about $50 million for 2026 and $175 million run-rate by the end of 2028.
The January year-end report is when Brown & Brown has said it will put numbers on the 2027 technology budget and the returns it expects.
Sources
- Brown & Brown (BRO) Reports Q3 Earnings: What Key Metrics Have to Say — Yahoo Finance
- Brown & Brown (BRO) Misses Q3 Earnings and Revenue Estimates — Yahoo Finance
- BRO Q3 Earnings Miss Estimates on Weak Growth, Margin Pressure — Yahoo Finance
- Brown & Brown (NYSE:BRO) reports sales below analyst estimates in Q3 2026 earnings — Yahoo Finance
- Brown & Brown: Q3 Earnings Snapshot — Associated Press